Oncology
Committed to improving the lives of people affected by cancer.
Tackling the Toughest Challenges in Oncology
Cancer is smart and ever-evolving. The same is true of our approach to attacking cancer. We collaborate with an extraordinary group of scientists, physicians, industry peers and patients to continually improve our understanding of cancer. Together, we work to tackle the toughest challenges in oncology.
16 new molecular compounds in Phase I, II or III clinical trials in oncology
200+ active clinical trials in oncology
20+ different cancers and tumor types being investigated
A Heritage of Research
For over 20 years, we’ve recognized that the best science comes from the best scientists. Together with our partners, we work to develop first-in-class medicines that aim to transform the way cancer is treated. We know that the introduction of new medicines is a significant milestone for cancer patients. And, it’s one of the reasons why our scientists and researchers continually push ahead to develop and deliver the latest breakthroughs in cancer treatment.
Oncology Discovery & Development
By investing in new technologies and approaches, and exploring new pathways and targets, we continually evolve our understanding, discovering new ways of treating some of the most complex and difficult-to-treat cancers, including hematologic and solid cancers.
Oncology Focus Areas
We focus our cancer research on protein-based therapeutics, small molecules, biologic therapeutics and combination technologies.
Oncology Collaborations
We bring together the best and brightest minds in oncology to tackle some of the world’s toughest and most difficult-to-treat cancers.